SCHEMBL6351845

SCHEMBL6351845

CN(C)c1cccc(C(=O)Nc2ccc(C#N)cc2C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.53
MEN1 O00255 5/20 0.53
GFER P55789 1/20 0.53
MAPT P10636 4/20 0.50
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 2/20 0.50
HPGD P15428 2/20 0.50
TDP1 Q9NUW8 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
RAF1 P04049 1/20 0.48
TP53 P04637 1/20 0.48
BRAF P15056 1/20 0.48
ALOX15 P16050 1/20 0.48
MAPK11 Q15759 1/20 0.48
MAPK14 Q16539 1/20 0.48
HSD17B10 Q99714 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6358978 0.87 ALB (0.55) KMT2AMEN1GFERMAPTALDH1A1
SCHEMBL6357568 0.84 ALDH1A1 (0.70) KMT2AMEN1GFERMAPTALDH1A1
SCHEMBL6351469 0.84 AKR1C2 (0.66) KMT2AMEN1GFERMAPTALDH1A1
SCHEMBL6353963 0.84 KMT2A (0.62) KMT2AMEN1GFERMAPTALDH1A1
SCHEMBL6357140 0.82 MEN1 (0.60) KMT2AMEN1GFERMAPTALDH1A1
SCHEMBL6357017 0.82 MEN1 (0.64) KMT2AMEN1GFERALDH1A1CYP1A2
SCHEMBL6358260 0.82 AKR1C2 (0.70) KMT2AMEN1GFERMAPTALDH1A1
SCHEMBL6359497 0.82 KMT2A (0.53) KMT2AMEN1GFERMAPTALDH1A1
SCHEMBL6359203 0.82 KMT2A (0.58) KMT2AMEN1GFERMAPTALDH1A1
SCHEMBL6349507 0.80 MEN1 (0.57) KMT2AMEN1GFERHDAC6PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 KMT2A 3645/4885MEN1 3274/4885GFER 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.